Long-term zidovudine responders: is there still rationale for HIV monotherapy? 1996

V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz
May 1998, AIDS (London, England),
V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz
July 1996, AIDS research and human retroviruses,
V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz
March 2020, Der Urologe. Ausg. A,
V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz
June 2018, MMW Fortschritte der Medizin,
V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz
October 2012, Revue des maladies respiratoires,
V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz
November 2013, Current drug targets,
V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz
May 1989, Leber, Magen, Darm,
V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz
October 2018, Nederlands tijdschrift voor tandheelkunde,
V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz
March 2016, AIDS (London, England),
V Soriano, and A Mas, and A Heredia, and A Vallejo, and I Hewlett, and J Epstein, and J González-Lahoz
January 1998, The Journal of the Association of Nurses in AIDS Care : JANAC,
Copied contents to your clipboard!